If your GLP-1 insurance coverage has been denied or has dropped — and you are already using this medication — you have documented options: requesting an internal appeal, asking your provider to re-submit a prior authorization with additional clinical notes, exploring state-level external review, and checking whether a patient assistance program applies to your situation. This guide is written for people already on GLP-1 medication in the United States who are navigating a coverage gap, denial, or unexpected change.
If you are still in the planning stage and want to know what questions to ask before you start, that conversation belongs with your provider — and our guide on questions to ask your doctor before starting GLP-1 covers that ground in detail.
What a Coverage Denial Actually Means
Receiving a denial notice does not automatically mean the medication is unavailable to you. Insurance denials come in several forms, and the type of denial shapes what your next step is.
| Denial Type | What It Means | Where This Typically Leads |
|---|---|---|
| Prior authorization (PA) denied | Your provider’s clinical documentation was incomplete, not submitted, or did not meet the plan’s internal criteria | PA resubmission with additional clinical notes; internal appeal if resubmission is denied |
| Formulary exclusion | The medication is not on your plan’s approved drug list for this indication — excluded at coverage level, not just pending documentation | Formulary exception request citing medical necessity; may also involve internal appeal |
| Step therapy requirement | Your plan requires you to try one or more alternative medications first before covering the requested one | Documentation of prior therapy history; exception or appeal if that step therapy was already completed |
| Coverage lapsed or dropped | Plan changed mid-year, policy renewed with a different formulary, or Medicaid coverage status changed | May have appeal pathways depending on timing and plan type; contact plan member services for your specific process |
The notice you receive should specify which of these applies. The denial reason code and the plan’s stated clinical criteria are the starting point for everything that follows.
Why GLP-1 Insurance Coverage Gaps Are Common
Access barriers for GLP-1 medications are well documented. A January 2026 analysis by Elizabeth Williams published by KFF found that only 13 state Medicaid programs covered GLP-1 medications for obesity treatment under fee-for-service at that time — down from 16 states in October 2025, with several states eliminating coverage due to budget pressures. The same analysis noted that even when covered, GLP-1 medications are “typically subject to utilization controls such as prior authorization, which can further limit access.”
Medicare coverage has followed a different, still-developing path. A June 2026 analysis by Juliette Cubanski and Nolan Sroczynski at KFF described the Medicare GLP-1 Bridge — a temporary program running through December 2027 — as covering obesity-indicated GLP-1 medications for beneficiaries who meet specific eligibility thresholds, some of which are stricter than FDA approval criteria. As of that analysis, an estimated 3.8 million Part D enrollees met all Bridge eligibility criteria in 2023 — representing 8% of Part D enrollees — while 13.3 million Medicare beneficiaries had obesity or overweight.
For employer-sponsored and marketplace plans, coverage varies significantly by plan and changes annually. This variability is part of why so many people find themselves in a coverage gap without warning.
What to Document Before You Take Any Next Step
Before calling your insurance company or reaching out to your provider’s office, gathering the right information saves time and reduces the chance of a gap in your record.
The denial notice itself. Keep the original, in whatever form it arrived. Note the date on the notice, the reason code or reason stated, the plan name, and any reference or case number.
Your prescription history. A printed or saved record of the prescriptions filled, how long you have been on the medication, and any dose adjustments — even if informal — gives your provider the raw material to write a stronger letter of medical necessity.
Your clinical response and side-effect record. If you have been tracking how the medication has affected you — appetite changes, weight, side effects, blood glucose readings if relevant — this record can support a “medically necessary” argument more concretely. The GLP-1 Side-Effect & Progress Tracker is designed to help you keep this kind of timestamped log between appointments.
Previous authorizations. If you had a prior authorization that was previously approved, keep that documentation. A renewal denial on a medication that was previously authorized is a different situation than a first-time denial.
What your provider’s notes say. Ask your provider’s office for a copy of the clinical notes that supported the original prescription. These may include diagnosis codes, lab values, or a narrative of why the medication was clinically appropriate for you — all of which may be needed in an appeal.
Keeping this material organized in one place — a folder, a notes app, or a printed packet — makes the next steps easier to execute.
Key step
Gather the denial notice, prescription history, and clinical response record before calling anyone.
How Prior Authorization Works — and How Re-Authorization Can Help
If your denial is a PA denial, the path forward typically starts with your provider’s office, not with you calling the insurance company directly.
What your provider’s office needs from you:
- The denial notice (so their staff can see the reason code)
- Your clinical response information (what changed or improved since starting)
- Any labs or measurements that have shifted
What a prior authorization letter typically includes:
- Diagnosis code and clinical indication
- Statement of medical necessity
- Relevant clinical history (prior treatments tried, if any)
- Provider’s professional judgment that the medication is appropriate
PA review timelines vary by plan and state regulations. Urgent reviews tied to a demonstrated medical need are typically processed more quickly than standard reviews — ask the insurance member services line what their specific timeline is for your request type.
Scripts for speaking with your provider’s office:
When you call to explain the situation:
“My insurance denied the prior authorization for my GLP-1 medication. I have the denial notice here and I can share the reason code. Can someone in the office help me understand what documentation you’d need to resubmit or file an appeal?”
When asking about your records:
“Can I get a copy of the clinical notes from my last appointment, specifically the ones that supported the GLP-1 prescription? I may need these for an appeal.”
When following up:
“I wanted to check on the status of the prior authorization resubmission. The denial reference number was [X]. Is there anything else the insurance company is asking for?”
Filing an Internal Appeal
If a PA resubmission does not resolve the denial, or if the issue is something other than a PA denial, an internal appeal is the next formal step. Under federal rules, most health plans are required to have an internal appeals process.
Time limits matter. Most plans have strict deadlines for filing an internal appeal. Your denial notice and your plan’s summary of benefits state the specific window — these deadlines vary by plan type and state, so the notice itself is the most reliable source. If your situation is urgent — meaning the denial is affecting a treatment you are currently relying on — ask whether your plan has an expedited appeal process.
What to include in an appeal:
- A brief, clear statement of what you are requesting and why
- A copy of the denial notice
- A letter of medical necessity from your provider
- Any clinical records supporting the prescription
- References to the plan’s own criteria (if you can access the plan’s formulary or PA criteria, quoting them back can be useful)
Scripts for calling the insurance member services line:
When opening the call:
“I’m calling to file an internal appeal on a prior authorization denial for my GLP-1 medication. The denial date was [date] and the reference number is [number]. Can you walk me through the process for submitting an appeal?”
When asking about expedited review:
“I am currently on this medication and a gap in treatment may affect my health. Does this plan have an expedited appeal option for situations like this?”
When documenting the call:
“Can I get the name or ID of the person I’m speaking with, and a confirmation number for this call? I’m keeping a log of all my contacts.”
Keep a log of every call: date, time, name of representative if given, what was said, and any next steps promised. If your appeal is submitted in writing, send it with delivery confirmation or via a method that creates a timestamp.
External Review — When the Internal Appeal Is Denied
If your internal appeal is denied, most states allow you to request an independent external review. This is conducted by an independent review organization, not affiliated with your insurance plan, and their decision is generally binding on the plan.
How to access external review:
- Your denial letter for the internal appeal should include instructions on how to request external review and the deadline for doing so — the deadline is stated in that letter, and varies by plan type and state rules.
- You can also contact your state department of insurance (sometimes called the division of insurance or office of the insurance commissioner). Each state has a consumer assistance function and most can help you understand your rights and how to initiate external review.
- If you have employer-sponsored insurance governed by ERISA (most large employer plans), federal external review rules apply rather than state rules — your denial notice should indicate which process governs your plan.
External review is a formal, documented process. The reviewer looks at the plan’s clinical criteria, your medical documentation, and whether the denial was consistent with the plan’s own terms and with medical standards. In some cases, independent reviewers overturn denials.
External review is conducted by an independent reviewer — not your insurance company. Your final internal appeal denial letter should include instructions for how to request it.
Other Access Pathways
If formal appeals are not resolving the issue, or while you wait for an appeal outcome, several parallel pathways may be worth exploring depending on your situation.
Manufacturer assistance programs. For some GLP-1 medications, manufacturers offer patient assistance programs for people who meet income criteria and are uninsured or underinsured. Because program names are tied to brand names, this guide cannot point to a specific one — but the manufacturer’s official website is the appropriate starting point. A pharmacist familiar with GLP-1 medications may be able to point you to what currently exists.
State pharmaceutical assistance programs. Some states have programs that help residents access medications when other coverage is unavailable. Eligibility criteria and available medications vary by state. Your state’s department of health or department of human services is the starting point.
Formulary exception requests. If the medication is excluded from your formulary, you may be able to request a formulary exception — a formal request that the plan cover a non-formulary drug based on medical necessity. This is similar to a PA appeal but specifically addresses formulary exclusions. Your provider’s office typically initiates this.
Patient advocacy organizations. Several nonprofit organizations specialize in helping patients navigate insurance coverage issues for high-cost medications. Searching for “patient advocacy” or “prescription assistance” alongside your diagnosis type may surface relevant organizations.
Talking to your provider about alternatives. If coverage cannot be restored in a reasonable timeframe, your provider may want to discuss whether any covered alternatives exist — not as a substitute for the appeal process, but as a parallel conversation. This is a clinical decision that belongs with your provider. For guidance on how to prepare for that conversation, the guide on talking to your doctor about GLP-1 covers how to document your progress and present it effectively.
If You End Up Stopping Due to Cost
Sometimes coverage gaps resolve. Sometimes they do not, and people end up stopping GLP-1 medication because the out-of-pocket cost is not sustainable. If that happens, understanding what the body does after stopping — and what to track — is worth knowing in advance. That topic is covered in our guide on what happens when you stop GLP-1.
How to Track Where You Are in the Process
Insurance appeals involve multiple parties, multiple deadlines, and a lot of phone calls. A simple tracking method — even just a notes document or a paper log — can be the difference between catching a missed deadline and losing an appeal you might have won.
For each contact or step, log:
- Date and what you did or sent
- Who you spoke with (name, title, ID if given)
- What they said would happen next
- The deadline for the next step
If you are already using the GLP-1 Side-Effect & Progress Tracker to log your clinical progress, that record can double as supporting documentation for your appeal — showing your provider and potentially your insurer a concrete timeline of how the medication has affected you.
The Bottom Line
A GLP-1 insurance denial is a process problem, not a final answer. The most effective responses — PA resubmission, internal appeal, external review — require documentation, deadlines, and coordination with your provider’s office. None of them are guaranteed to succeed, but each one is a legitimate step that many people have used to restore access.
If you find yourself in this situation, the documentation you have already accumulated — prescription history, clinical notes, a progress log — becomes your most practical tool.